News Release
London, 2 August 2013
For immediate release
Statement regarding Smiths Medical
Further to the announcement made on 31 May 2013 about a preliminary approach for the Medical division, Smiths Group announces that it has not proved possible to reach agreement with the potential counterparty on acceptable terms for a transaction. Discussions have therefore been terminated.
In reaching this conclusion, the Board has taken full account of the quality and highly cash generative nature of Smiths Medical, both standalone and in the context of the Group as a whole.
ENDS
Investor Relations
Peter Durman: +44 (0)20 7808 5535
Media Relations
Anthony Cardew - Cardew Group: +44 (0)20 7930 0777 / +44 (0)7770 720389
Colin McSeveny: +44 (0)20 7808 5534
Smiths Group
Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs around 23,000 people in over 50 countries. For more information visit www.smiths.com
